Chris Temple kicks off today with an update on Sarepta and the FDA press release about expanding the “compassionate use” policy. We discuss how this impacts Sarepta moving forward in terms of finances and approval likelihood. We then shift focus to the many news stories that are coming today and tomorrow which are holding back any major moves in the markets.
Click download link to listen on this device: Download Show